7月9日,亿帆医药(002019)在回复投资者时表示,目前易尼康处于快速放量阶段。丁甘交联玻璃酸钠注射液适用于对非药物保守治疗及单纯止痛药物治疗疼痛缓解效果欠佳的膝骨关节炎(OA)成人患者。2017年12月,亿帆医药全资子公司亿帆国际医药有限公司与LG Chem,Ltd.签署产品授权协议,获得丁甘交联玻璃酸钠注射液在中国境内及澳大利亚的独家进口经销权,并由亿帆医药独自负责丁甘交联玻璃酸钠注射液在...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.